tiprankstipranks
Trending News
More News >
Incannex Healthcare Limited Sponsored ADR (IXHL)
NASDAQ:IXHL
US Market
Advertisement

Incannex Healthcare Limited Sponsored ADR

Compare
882 Followers

IXHL Stock Chart & Stats

$0.36
-$0.11(-5.37%)
At close: 4:00 PM EST
$0.36
-$0.11(-5.37%)

Incannex Healthcare Limited Sponsored ADR News

IXHL FAQ

What was Incannex Healthcare Limited Sponsored ADR’s price range in the past 12 months?
Incannex Healthcare Limited Sponsored ADR lowest stock price was $0.08 and its highest was $3.12 in the past 12 months.
    What is Incannex Healthcare Limited Sponsored ADR’s market cap?
    Incannex Healthcare Limited Sponsored ADR’s market cap is $121.14M.
      When is Incannex Healthcare Limited Sponsored ADR’s upcoming earnings report date?
      Incannex Healthcare Limited Sponsored ADR’s upcoming earnings report date is Nov 13, 2025 which is in 14 days.
        How were Incannex Healthcare Limited Sponsored ADR’s earnings last quarter?
        Currently, no data Available
        Is Incannex Healthcare Limited Sponsored ADR overvalued?
        According to Wall Street analysts Incannex Healthcare Limited Sponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Incannex Healthcare Limited Sponsored ADR pay dividends?
          Incannex Healthcare Limited Sponsored ADR does not currently pay dividends.
          What is Incannex Healthcare Limited Sponsored ADR’s EPS estimate?
          Incannex Healthcare Limited Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Incannex Healthcare Limited Sponsored ADR have?
          Incannex Healthcare Limited Sponsored ADR has 347,705,500 shares outstanding.
            What happened to Incannex Healthcare Limited Sponsored ADR’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Incannex Healthcare Limited Sponsored ADR?
            Currently, no hedge funds are holding shares in IXHL

            Incannex Healthcare Limited Sponsored ADR Stock Smart Score

            1
            Underperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Company Description

            Incannex Healthcare Limited Sponsored ADR

            Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

            Incannex Healthcare Limited Sponsored ADR (IXHL) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Assertio Therapeutics
            Cumberland Pharmaceuticals
            China SXT Pharmaceuticals
            Journey Medical Corp
            BioAge Labs, Inc.

            Ownership Overview

            0.03%<0.01%0.11%99.70%
            0.03%
            Insiders
            0.11% Other Institutional Investors
            99.70% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis